Product LaunchThe launch of PuriFi, a novel hemoperfusion pump, continues to go well with many evaluations ongoing.
Product Revenue GrowthProduct revenues increased by 25% year-over-year and 6% quarter-over-quarter, driven by a 28% increase in direct sales outside of Germany and a 22% increase in global distributor sales.
Regulatory ApprovalThe regulatory approval of DrugSorb-ATR in the U.S. and Canada could make it the first device indicated for the removal of antithrombotic agents during cardiac surgery in these markets.